Theme: Advanced treatment method for infectious and rare diseases

Infectious Diseases 2020

Renowned Speakers

Infectious Diseases 2020

Infectious Diseases 2020

July 20 - July 21, 2020 | Vancouver, Canada

Conference Series LLC Ltd welcomes you to attend the Infectious and Rare Diseases Conference to be held in Vancouver, Canada on July 20 - July 21, 2020The theme for the conference this year is Advanced Treatment Method For Infectious and Rare Diseases

Details of Infectious Diseases 2020 Conferences in Canada

Conference Name Place Date
Infectious Diseases 2020 Vancouver, Canada July 20 - July 21, 2020

Infectious Diseases and Neuro Infectious Diseases, Infectious Diseases Prevention, Control and Cure, Bacterial & Fungal Infectious Diseases, Clinical Research and Public Awareness, Ebola and Zika Viral Infections, Global Trends in Emerging Infectious Diseases, HIV/AIDS, Immunology of Infections, Malaria and Hepatitis, New Antiviral, Antibacterial and Antifungal Agents, Nosocomial Infections, Parasitic Diseases, Pediatric Infectious Diseases/ Childhood Infectious Diseases, Rare Diseases in Cancer and Aging, Rare Infectious Diseases and Immune Deficiencies, Respiratory Diseases, Sexually Transmitted Diseases/ Sexually Transmitted Infections, Surgical Site Infections, Tuberculosis, Vaccines and Vaccination,Viral Infectious Diseases

Infectious Diseases 2020 conferences invites all the participants from all over the world to attend “7th International Conference on Infectious and Rare Diseases” during July 20-21, 2020 Vancouver, Canada which includes prompt keynote presentations, special sessions, workshops, symposiums, oral talks, poster presentations and exhibitions. The conference focuses on “Advanced treatment method for infectious and rare diseases”.

Infectious and Rare Diseases 2020 Conference aims to provide the best platform to all the researchers working in Infectious & Rare Diseases Research, Infectious Drugs developers, Healthcare sector, regulatory & health authorities, patient organisations, patient advocacy, Clinical Trials & Research, and public policy individuals.

This Infectious Diseases 2020 conference will offer a proper platform which will provide a unique platform for all the stakeholders in the Infectious Drug Industry sector to discuss current issues, trends and innovations in Infectious & Rare Diseases Research development and to network with hospitals, Research labs, Pharma-Biopharma Companies, Infectious Diseases Drug developers, and non-profit organizations etc.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases like Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

  • Who can attend? 

    The Infectious and Rare Diseases 2020 Conferences bring together the senior level attendees and speakers from both academics, clinical research institutes, Clinical laboratories, Hospitals and from the top Biopharmaceutical companies from across the globe. Participants includes Directors, Deans, Research Professors, VPs, CTOs, Laboratory heads, Drug Developers, Clinical Trials Researchers, clinical trials sponsors, CROs, Medical doctors, & Researchers.

  • Who to attend?

    • Bacteriologists
    • Clinical Trials & Clinical Research
    • Commercial Development of Drugs
    • Drug Discovery & Development
    • Epidemiologists
    • Genetic Diseases
    • Health Care Professionals
    • Immunology & Inflammatory Disease
    • Infection Prevention and Infection Control Specialists
    • Infectious Diseases Specialists
    • Microbiologists
    • Molecular Diagnostics & Diagnostic Product developers
    • Mycologists
    • Oncologist and Cancer experts
    • Infectious & Rare Diseases Foundations/Associations
    • Parasitologists
    • Patient Advocacy, Market Access, Pricing & Reimbursement
    • Personalized, Translational, Experimental, & Regenerative Medicine
    • Pharmacists & Pharma Industry
    • Rare & ultra-rare Diseases
    • Regulatory & Medical Affairs
    • Targeted Therapy, Cell & Gene Therapy
    • Virologists
  • Why to attend?

    • Keynote Sessions
    • Workshop & Symposia
    • Networking & B2B (Business to Business Meeting)
    • B2C (Business to Customers)
    • Q&A sessions with the keynote speakers
    • Best research & Poster Award
  • Benefits:

Track 1: Infectious Diseases and Neuro Infectious Diseases

The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

Neuro infectious diseases are the infectious diseases which are observed in the nervous system. Viral and immune mediated disorders of the nervous system are among the most challenging neurological disorders. The most common neuro immune disorder is multiple sclerosis and hiv is the most common viral infection of the nervous system.

Track 2: Infectious Diseases Prevention, Control and Cure

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials.

Track 3: Bacterial & Fungal Infectious Diseases

These infectious organisms are known as pathogens. Examples of pathogens encompass bacteria, viruses, fungi, and prions.  Contamination is the impact of a foreign organism in the frame. Varieties of contamination encompass bacterial, fungal, viral, protozoan, parasitic, and prion disease. Skin is a barrier this is supposed to defend you from bacteria, but microorganism can typically be observed dwelling at the pores and skin of wholesome individuals. A spoil inside the pores and skin can exchange this scenario from an innocent one to one wherein the character can turn out to be ill.

Track 4: Rare Infectious Diseases and Immune Deficiencies

Globally, about one-third of human deaths are attributable to infections. In addition, the so-called non-infectious causes of death often have a mysterious infectious etiology. Many rare diseases or orphan diseases caused by infectious agents rather than genetic or environmental factors.

Track 5: Rare Diseases in Cancer and Aging

Rare cancers tend to be caused by simple genetic mutations, and common cancers tend to be caused by a complex set of genetic and epigenetic aberrations that continually increase in number as the tumor develops. All cancers that can be cured when in an advanced clinical stage are rare cancers. Rare cancer syndromes typically produce various types of cancers, including rare cancers and common cancers.

Aging is a collection of degenerative changes that occur in organisms that lack the ability to perpetually regenerate. Age is a major risk factor for most common neurodegenerative diseases. Dementia becomes more common with age. The spectrum includes mild cognitive impairment, Alzheimer's disease, cerebrovascular disease, Parkinson's disease and Lou Gehrig's disease. Rare diseases provide much insight into the cellular processes that hasten the aging process.

Track 6: Global Trends in Emerging Infectious Diseases

An Infectious disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Track 7: Ebola and Zika Viral Infections

Ebola viral infection is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola virus disease symptoms are very severe which appears in 2-3 days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhoea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death. 

Zika virus disease is caused by a virus transmitted primarily by aedes mosquitoes. People with zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain and malaise or headache.

Track 8: Clinical Research and Public Awareness

Clinical research is a branch of healthcare science. The first step in tackling this challenge is regularly getting the public to think about participating in clinical research. People need to consider how they can help advance the prevention, diagnosis, and treatment of disease. It is never too early to consider participation whether or not someone ultimately chooses to join a study.

Track 9: HIV/AIDS

Acquired immunodeficiency syndrome (AIDS) is a persistent, doubtlessly lifestyles-threatening condition due to the human immunodeficiency virus (HIV). By damaging your immune machine, HIV interferes with your frame's ability to fight the organisms that purpose sickness. HIV is a sexually transmitted contamination (STI). The immune gadget allows the frame to combat off infections. Untreated HIV infects and kills CD4 cells, that is a type of immune cellular referred to as T cells. Over time, as HIV kills extra CD4 cells, the body is more likely to get various kinds of infections and cancers.

Track 10: Pediatric Infectious Diseases/ Childhood Infectious Diseases

Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Track 11: Respiratory Diseases

Respiratory illness is a medicinal term that incorporates obsessive conditions influencing the organs and tissues that make gas trade conceivable in higher life forms, and incorporates states of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural depression, and the nerves and muscles of relaxing. Respiratory maladies run from mellow and self-constraining, for example, the regular cool, to life-debilitating substances like bacterial pneumonia, aspiratory embolism, and lung tumor. The investigation of respiratory illness is known as pulmonology. A specialist who represents considerable authority in respiratory sickness is known as a pulmonologist, a mid-section medication expert, a respiratory prescription pro, a respirologist or a thoracic drug pro. UBET Respiratory illnesses can be arranged in a wide range of routes, including by the organ or tissue required, by the sort and example of related signs and indications, or by the cause (etiology) of the ailment.

Track 12: Sexually Transmitted Diseases/ Sexually Transmitted Infections

Sexually transmitted diseases/ sexually transmitted infections are the infectious diseases which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex.

Track 13: Viral Infectious Diseases

Viral Infectious Disease happens when a life form's body is attacked by pathogenic infections, and irresistible infection particles (virions) append to and enter vulnerable cells. There are numerous sorts of infections that cause a wide assortment of viral sicknesses. The most widely recognized kind of viral malady is the normal cool, which is brought about by a viral disease of the upper respiratory tract (nose and throat). Viral infections are infectious and spread from individual to individual when an infection enters the body and starts to duplicate. Viral maladies result in a wide assortment of manifestations that differ in character and seriousness relying upon the kind of viral contamination and different components, including the individual's age and general wellbeing.

Track 14: Malaria and Hepatitis

Malaria is a mosquito borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases it can cause yellow skin, seizures, comaor and even death.

Hepatitis is caused by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. Hepatitis may occur with limited or no symptoms but often leads to jaundice, poor appetite and malaise. Hepatitis is acute when it lasts less than six months and chronic when it persists longer.

Track 15: Immunology of Infections

Immunology of infections means the battle between pathogens and the host immune defences. Immunology is the branch of science concerned with the various aspects related to immune system, innate and acquired immunity. Immunology also deals with laboratory techniques involving the interaction of antigens with specific antibodies.

Track 16: Vaccines and Vaccination

Vaccines are the products that are able to produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism.

Track 17: Tuberculosis

Tuberculosis is a bacterial infection caused by a bacterium called mycobacterium tuberculosis which spread through the lymph nodes and blood stream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine and brain.

Track 18: New Antiviral, Antibacterial and Antifungal Agents

Bacterial resistance is a developing danger but then couple of new anti-toxins dynamic against multi-safe microscopic organisms is being investigated. A blend of falling benefits, administrative components and unreasonable and unwise utilization of anti-toxins has prompted to a disturbing circumstance where a few diseases have no cure. In this article, we compress the new advancements that have been recommended to influence the pharmaceutical enterprises toward the field of diseases. We likewise quickly say the new mixes not too far off and some recently affirmed aggravates that may help us hold over this emergency.

Track 19: Nosocomial Infections

Nosocomial contaminations are diseases are obtained in doctor's facilities and other human services offices. To be delegated a Nosocomial disease, the patient probably been conceded for reasons other than the contamination. He or she should likewise have hinted at no dynamic or brooding contamination. Urinary tract contaminations are the most widely recognized kind of nosocomial disease. In the United States, surgical site diseases, circulatory system contaminations, and pneumonia are the other most basic sorts. The area of a nosocomial disease relies on upon the way of a patient's healing facility technique. 

Track 20: Parasitic Diseases

A parasitic illness is an irresistible infection brought about or transmitted by a parasite. Numerous parasites don't bring about ailments. Parasitic ailments can influence basically all living beings, including plants and well evolved creatures. The investigation of parasitic illnesses is called parasitology. A few parasites like Toxoplasma gondii and Plasmodium spp. can bring about malady straightforwardly, yet different creatures can bring about infection by the poisons that they deliver. In spite of the fact that life forms, for example, microscopic organisms work as parasites, the utilization of the expression "parasitic sickness" is typically more limited. The three primary sorts of life forms creating these conditions are protozoa (bringing on protozoan disease), helminths (helminthiasis), and ectoparasites. Protozoa and helminths are generally endoparasites (normally living inside the body of the host), while ectoparasites typically live on the surface of the host. Once in a while the meaning of "parasitic ailment" is limited to infections because of endoparasites.

Track 21: Surgical Site Infections

Surgical site infections are the infections which may occur within 30 days after the operation and are observed in the parts of skin and subcutaneous tissue of the incision.


Scope and Importance of Infection Control:

Every year, lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious diseases. These steps are part of infection control.  Infection prevention and control measures aim to ensure the protection of those who might be vulnerable to acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. The basic principle of infection prevention and control is hygiene. Healthcare personnel might need to take additional infection control steps if a PUI or patient with confirmed EVD has other conditions or illnesses caused by specific infectious diseases, such as tuberculosis. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Splashes to unprotected mucous membranes (for example, the eyes, nose, or mouth) are particularly hazardous. Procedures that can increase environmental contamination with infectious material or create aerosols should be minimized. healthcare personnel (HCP) refers all people, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or aerosols generated during certain medical procedures. HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and people not directly involved in patient care (clerical, dietary, housekeeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.

Market Research on Infectious Diseases

The global market for infectious disease treatments was valued at $64.8 billion in 2017. This market is expected to increase at a compound annual growth rate (CAGR) of 8.9% to reach $99 billion in 2022. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. Increasing external funding for research and development (R&D) activities and proactive government initiatives are among the primary growth stimulants for the market.

Infectious Disease Market Insights
  • The infectious disease treatment market in China is witnessing steady growth owing to an increasing use of combination therapies. We forecast the growth of this market to continue through 2020.
  • Both government and non-government bodies are increasing awareness of influenza vaccinations. This rising awareness is driving growth for the influenza vaccine market.
  • An increase in R&D activities for liver cirrhosis medication is a major trend expected to impact the liver disease treatment market. We expect this market to witness strong growth through 2021.
Infectious Diseases Market Share and Segmentation

Within our infectious diseases industry research, we provide deep insights into the market landscape, its segments, and their market share. Our research experts segment this market by infectious diseases according to virus, bacteria, prions, mycosis, and protozoal.

Our infectious diseases market segmentation research offerings include:

Infectious Disease By Virus
  • Influenza market
  • Parainfluenza market
  • HIV market
  • Liver Infections market
    • Hepatitis A market
    • Hepatitis B market
    • Hepatitis C market
Infectious Disease by Bacteria
  • Cholera market
  • Meningitis market
  • Staphylococcal and streptococcal infections market
  • Salmonella market
Infectious Disease by Prions
  • Fatal familial insomnia market
  • Kuru market
  • Creutzfeldt-Jakob disease market
Infectious Disease by Mycosis (fungal infections)
  • Athlete's foot (tinea pedis) market
  • Tinea capitis market
  • Aspergillosis market
  • Onychomycosis market
Infectious Disease by Protozoal
  • Kritosporidiosis market
  • Amebiasis market
  • Izosporiasis market
  • Babesiosis market
Major Infectious Disease Societies around the Globe
  • European Society of Clinical Microbiology and Infectious Diseases
  • International Union of Microbiological Societies
  • Federation of Infection Societies
  • Canadian Society of Microbiologists
  • British Infection Association
  • Federation of European Microbiological Societies
  • Welsh Microbiology Association
  • Clinical Virology Network
  • American Society for Microbiology
  • Society for General Microbiology
  • Infectious Diseases Society of America
Universities related to Infectious Diseases
  • University of Cambridge
  • Kings College of London
  • London School of Hygiene and Tropical Medicine
  • Imperial College London
  • UCL Institute of Epidemiology and Health care
  • University of Sheffeild
  • Pediatric Infectious Diseases Society
  • Columbia University
  • University of Maryland
  • Swedish Institute for Infectious Disease Control
  • Uppsala University
  • University of Gothenburg
  • University of Otago
  • Oslo University
  • University of Pittsburgh
  • Emory Health Sciences
  • Queensland University of Technology
  • University of Liverpool
  • University of Colorado Denver
  • Infectious Diseases Society of America
  •  Medical College of Georgia at Georgia Regents University

Planning a Trip to Vancouver, Canada!!! Attending Meeting!!!

An issue with VISA!!

Infectious Diseases Committee will be happy to help you in all regards to plan your trip to Vancouver, Canada. Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA.

Find out what you need to do to visit Canada as a tourist or business person, how to extend your stay in Canada and what documents you need to carry with you to transit through Canada.

Application submission:

Canada does not have a visa office in every country so it is important that Delegates/Attendees visit the website of the visa office responsible for processing their visa applications.  Information is available on the website on how to submit a visa application and the documentation required. 

Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications (e-Apps).


This system allows clients to submit applications online.

Delegates/Attendees that need a visa but require their passport for other travel purposes are strongly encouraged to submit their visa applications online (e-Apps).  Delegates/Attendees that choose to apply online will not have to submit their passport until a decision has been taken on their applications.  If required, the visa office will send the applicant instructions on how and where to send their passports to finalize the visa process.  

Visa Application Centres (VACs):

VACs are commercial service providers authorized by Canada to provide specific services to applicants. 

VACs provide a number of services including help applicants fill out forms, answer questions and ensure that applications are complete, thereby reducing unnecessary delays or refusals due to incomplete applications.

Applicants that are required to provide biometrics information as part of the visa application process can do so at a VAC.  Additional information on the biometrics requirements is available at the IRCC website.

VACs send applications to Visa Offices and transmit decisions to applicants in a secure and confidential manner. VACs do not process visa applications and play no role in the decision-making process.

Visa Applications Processing Time:

Processing time for visa applications vary depending on the office and the time of the year.  Participants should be encouraged to apply early for their visas, and to submit complete applications including all supporting documents.  

Please visit the IRCC website for information on the time it takes to process visa applications at the various visa offices. 

NEW - Electronic Travel Authorization (eTA)

As of March 15, 2016, visa-exempt foreign nationals are expected to have an Electronic Travel Authorization (eTA) to fly to or transit through Canada. Exceptions include U.S. citizens and travelers with a valid Canadian visa. Canadian citizens, including dual citizens, and Canadian permanent residents are not eligible to apply for an eTA.

However, from March 15, 2016, until fall 2016, travellers who do not have an eTA can board their flight, as long as they have appropriate travel documents, such as a valid passport. During this time, border services officers can let travellers arriving without an eTA into the country, as long as they meet the other requirements to enter Canada. We invite you to consult the IRCC website regularly for information updates on eTA.

Best Tourist Destination: Vancouver

  • Stanley Park
  • Granville Island
  • Grouse Mountain
  • Museum of Anthropology
  • Kitsilano Beach
  • Gastown
  • Canada Place
  • Chinatown
  • English Bay
  • Capilano Suspension Bridge
  • Robson Street
  • Museum of Vancouver
  • Queen Elizabeth Park
  • Science World
  • Richmond & Many more…

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date July 20-21, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1
Poster Opportunity Closed Click Here to View